title: A case of social phobia and avoidant personality disorder with erectile dysfunction successfully treated with venlafaxine and add-on reboxetine.
abstract: A 25-year-old man with DSM-IV-TR Axis I social phobia and Axis II avoidant personality disorder and erectile dysfunction, presenting with depression, anxiety and insomnia, responded partially to extended release oral venlafaxine (75 mg/die for 6 weeks), but developed side effects and worsening symptoms when dose was increased to 150 mg/die; he responded to a combination of 75 mg/die venlafaxine and 4 mg/die reboxetine and improved on most of his symptoms.
authors.affiliation: Department of Psychiatry, University of Rome, La Sapienza-Sant'Andrea Hospital, 1035-1039 Via di Grottarossa, 00189 Rome, Italy. isabella.pacchiarotti@uniroma1.it
authors.forename: Isabella
authors.initials: I
authors.lastname: Pacchiarotti
authors.forename: Giovanni
authors.initials: G
authors.lastname: Manfredi
authors.forename: Giorgio D
authors.initials: GD
authors.lastname: Kotzalidis
authors.forename: Amedeo
authors.initials: A
authors.lastname: Ruberto
authors.forename: Roberto
authors.initials: R
authors.lastname: Tatarelli
authors.forename: Paolo
authors.initials: P
authors.lastname: Girardi
mesh_terms: D000328:Adult; D003511:Cyclohexanols / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D007172:Erectile Dysfunction / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009025:Morpholines / Q000627:therapeutic use*; D010554:Personality Disorders / Q000150:complications* / Q000188:drug therapy* / Q000523:psychology; D010698:Phobic Disorders / Q000150:complications* / Q000175:diagnosis / Q000523:psychology; D000077593:Reboxetine; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D000069470:Venlafaxine Hydrochloride
chemical_list: D003511:Cyclohexanols; D009025:Morpholines; D000077593:Reboxetine; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride